Cancer Institute A national cancer institute
designated cancer center

Philip W. Lavori

Publication Details

  • Antioxidant treatment of tardive dyskinesia PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS Rotrosen, J., Adler, L., Lohr, J., Edson, R., Lavori, P. 1996; 55 (1-2): 77-81


    Tardive dyskinesia (TD) is a frequently occurring side effect of treatment with neuroleptic antipsychotic drugs. TD is a persistent and often irreversible syndrome characterized by abnormal movements, including lingual and orofacial dyskinesia, grimacing, tics, choreic movements of the limbs and trunk, and athetosis and dystonia. In some patients the muscles of respiration and speech may also be involved. There is no established treatment for TD.

    View details for Web of Science ID A1996VK01400014

    View details for PubMedID 8888127

Stanford Medicine Resources:

Footer Links: